Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
3
×
fda
480 biomedical
ally bridge group
arsenal medical
big data analytics
biotech ipos
blackrock
bob langer
casdin capital
chronic rhinosinusitis
covid-19
deals
diabetic nephropathy
drug delivery
dyne therapeutics
eventide asset management
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
inflammation
investing
ipo
irving investors
jay ghosh
keros therapeutics
lyra therapeutics
medical device
metacrine
mometasone furorate
myotonic dystrophy type 1
national top stories
nonalcoholic steatohepatitis
What
company
3
×
ipo
million
3
×
raised
biotech
developing
drug
genetic
medicines
new
raises
therapeutics
analysis
bio
bring
brings
debut
develop
diseases
disorders
dyne
dyne’s
employing
goldfinch
kidney
late
later
lead
lyra
markets
muscle
muscular
nose
noses
persistently
preclinical
public
rare
runny
stage
Language
unset
3
×
Current search:
unset
×
million
×
company
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses